PE20010402A1 - Derivados de 1,5-dihidropirrol-2-ona sustituida - Google Patents
Derivados de 1,5-dihidropirrol-2-ona sustituidaInfo
- Publication number
- PE20010402A1 PE20010402A1 PE2000000761A PE0007612000A PE20010402A1 PE 20010402 A1 PE20010402 A1 PE 20010402A1 PE 2000000761 A PE2000000761 A PE 2000000761A PE 0007612000 A PE0007612000 A PE 0007612000A PE 20010402 A1 PE20010402 A1 PE 20010402A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- heteroaryl
- aryl
- cor8
- dihydropyrrolt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Pulmonology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19936719A DE19936719A1 (de) | 1999-08-06 | 1999-08-06 | Substituierte 1,5-Dihydropyrrol-2-on-Derivate |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20010402A1 true PE20010402A1 (es) | 2001-05-05 |
Family
ID=7917172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2000000761A PE20010402A1 (es) | 1999-08-06 | 2000-08-01 | Derivados de 1,5-dihidropirrol-2-ona sustituida |
Country Status (25)
Country | Link |
---|---|
US (1) | US6642267B2 (de) |
EP (1) | EP1200402B1 (de) |
JP (1) | JP2003506437A (de) |
KR (1) | KR20020025214A (de) |
CN (1) | CN1378532A (de) |
AR (1) | AR028848A1 (de) |
AT (1) | ATE304530T1 (de) |
AU (1) | AU782435B2 (de) |
BR (1) | BR0013311A (de) |
CA (1) | CA2381033A1 (de) |
CO (1) | CO5200758A1 (de) |
CZ (1) | CZ2002441A3 (de) |
DE (2) | DE19936719A1 (de) |
ES (1) | ES2248104T3 (de) |
HK (1) | HK1046405A1 (de) |
HU (1) | HUP0201937A3 (de) |
IL (1) | IL147977A0 (de) |
MX (1) | MXPA02001212A (de) |
NO (1) | NO20020574L (de) |
NZ (1) | NZ516988A (de) |
PE (1) | PE20010402A1 (de) |
PL (1) | PL353854A1 (de) |
SK (1) | SK1702002A3 (de) |
WO (1) | WO2001010833A1 (de) |
ZA (1) | ZA200201788B (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1269482C (zh) * | 2001-05-18 | 2006-08-16 | 威克斯医药有限公司 | 钠离子通道阻断剂和阿片类镇痛剂在制备用于对哺乳动物进行协同镇痛的药物中的应用 |
US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
US20060063802A1 (en) | 2004-03-29 | 2006-03-23 | Matthieu Guitton | Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
US8268866B2 (en) | 2004-03-29 | 2012-09-18 | Matthieu Guitton | Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
US9072662B2 (en) | 2004-03-29 | 2015-07-07 | Auris Medical Ag | Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
EP2425845A1 (de) * | 2004-12-23 | 2012-03-07 | Voyager Pharmaceutical Corporation | Acetylcholinesterasehemmer und Leuprolidacetat zur Behandlung von Alzheimer-Krankheit |
DK1928405T3 (da) * | 2005-09-28 | 2014-12-15 | Auris Medical Ag | Farmaceutiske sammensætninger til behandling af indre øreforstyrrelser |
WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
US9126987B2 (en) | 2006-11-30 | 2015-09-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
CN101668525A (zh) | 2007-03-01 | 2010-03-10 | 前体生物药物股份公司 | 谷氨酰胺酰环化酶抑制剂的新用途 |
EP2142514B1 (de) | 2007-04-18 | 2014-12-24 | Probiodrug AG | Thioharnstoffderivate als glutaminylcyclaseinhibitoren |
US8846315B2 (en) | 2008-08-12 | 2014-09-30 | Zinfandel Pharmaceuticals, Inc. | Disease risk factors and methods of use |
US8815508B2 (en) | 2008-08-12 | 2014-08-26 | Zinfandel Pharmaceuticals, Inc. | Method of identifying disease risk factors |
SG178953A1 (en) | 2009-09-11 | 2012-04-27 | Probiodrug Ag | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
ES2586231T3 (es) | 2010-03-03 | 2016-10-13 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
DK2545047T3 (da) | 2010-03-10 | 2014-07-28 | Probiodrug Ag | Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5) |
WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
EA201691399A1 (ru) | 2011-01-10 | 2016-10-31 | Зинфандел Фармасьютикалз, Инк. | Способы и готовые лекарственные формы для лечения болезни альцгеймера |
ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
KR102084185B1 (ko) | 2013-08-29 | 2020-03-04 | 주식회사 대웅제약 | 테트라히드로사이클로펜타피롤 유도체 및 이의 제조방법 |
US10708389B2 (en) * | 2016-12-06 | 2020-07-07 | Intelligrated Headquarters, Llc | Phased deployment of scalable real time web applications for material handling system |
PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL258360A (de) * | 1960-11-25 | |||
DE3434562A1 (de) * | 1984-09-20 | 1986-03-27 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verwendung von pyrrothinderivaten |
GB2173499A (en) * | 1985-02-04 | 1986-10-15 | Ici Plc | Fungicidal dithiolopyrrolones |
GB2170498A (en) * | 1985-02-04 | 1986-08-06 | Ici Plc | Processes for making fungicidal dithiolopyrrolones |
GB9210393D0 (en) * | 1992-05-15 | 1992-07-01 | Merck Sharp & Dohme | Therapeutic agents |
-
1999
- 1999-08-06 DE DE19936719A patent/DE19936719A1/de not_active Ceased
-
2000
- 2000-07-25 BR BR0013311-6A patent/BR0013311A/pt not_active IP Right Cessation
- 2000-07-25 NZ NZ516988A patent/NZ516988A/en unknown
- 2000-07-25 SK SK170-2002A patent/SK1702002A3/sk not_active Application Discontinuation
- 2000-07-25 KR KR1020027001608A patent/KR20020025214A/ko not_active Application Discontinuation
- 2000-07-25 CN CN00813944A patent/CN1378532A/zh active Pending
- 2000-07-25 AU AU68279/00A patent/AU782435B2/en not_active Ceased
- 2000-07-25 JP JP2001515300A patent/JP2003506437A/ja not_active Withdrawn
- 2000-07-25 ES ES00956273T patent/ES2248104T3/es not_active Expired - Lifetime
- 2000-07-25 MX MXPA02001212A patent/MXPA02001212A/es active IP Right Grant
- 2000-07-25 DE DE50011178T patent/DE50011178D1/de not_active Expired - Lifetime
- 2000-07-25 WO PCT/EP2000/007100 patent/WO2001010833A1/de active IP Right Grant
- 2000-07-25 IL IL14797700A patent/IL147977A0/xx unknown
- 2000-07-25 AT AT00956273T patent/ATE304530T1/de active
- 2000-07-25 CA CA002381033A patent/CA2381033A1/en not_active Abandoned
- 2000-07-25 HU HU0201937A patent/HUP0201937A3/hu unknown
- 2000-07-25 CZ CZ2002441A patent/CZ2002441A3/cs unknown
- 2000-07-25 EP EP00956273A patent/EP1200402B1/de not_active Expired - Lifetime
- 2000-07-25 PL PL00353854A patent/PL353854A1/xx not_active Application Discontinuation
- 2000-07-31 AR ARP000103963A patent/AR028848A1/es not_active Application Discontinuation
- 2000-08-01 PE PE2000000761A patent/PE20010402A1/es not_active Application Discontinuation
- 2000-08-03 CO CO00058413A patent/CO5200758A1/es not_active Application Discontinuation
-
2002
- 2002-02-05 NO NO20020574A patent/NO20020574L/no not_active Application Discontinuation
- 2002-02-06 US US10/066,800 patent/US6642267B2/en not_active Expired - Fee Related
- 2002-03-04 ZA ZA200201788A patent/ZA200201788B/xx unknown
- 2002-10-28 HK HK02107776.3A patent/HK1046405A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AU782435B2 (en) | 2005-07-28 |
PL353854A1 (en) | 2003-12-01 |
HUP0201937A2 (en) | 2002-10-28 |
EP1200402A1 (de) | 2002-05-02 |
NZ516988A (en) | 2004-11-26 |
ZA200201788B (en) | 2003-08-27 |
DE19936719A1 (de) | 2001-02-15 |
HUP0201937A3 (en) | 2002-12-28 |
IL147977A0 (en) | 2002-09-12 |
AU6827900A (en) | 2001-03-05 |
CN1378532A (zh) | 2002-11-06 |
DE50011178D1 (de) | 2005-10-20 |
EP1200402B1 (de) | 2005-09-14 |
CZ2002441A3 (cs) | 2002-05-15 |
MXPA02001212A (es) | 2002-07-02 |
CA2381033A1 (en) | 2001-02-15 |
US6642267B2 (en) | 2003-11-04 |
CO5200758A1 (es) | 2002-09-27 |
WO2001010833A1 (de) | 2001-02-15 |
ATE304530T1 (de) | 2005-09-15 |
US20020161033A1 (en) | 2002-10-31 |
KR20020025214A (ko) | 2002-04-03 |
SK1702002A3 (en) | 2002-07-02 |
AR028848A1 (es) | 2003-05-28 |
NO20020574L (no) | 2002-03-25 |
BR0013311A (pt) | 2003-01-28 |
ES2248104T3 (es) | 2006-03-16 |
NO20020574D0 (no) | 2002-02-05 |
JP2003506437A (ja) | 2003-02-18 |
HK1046405A1 (zh) | 2003-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20010402A1 (es) | Derivados de 1,5-dihidropirrol-2-ona sustituida | |
CY1120169T1 (el) | Παραγωγο αμιδιου και φαρμακο | |
PE20030702A1 (es) | Inhibidores de pde9 para tratamiento de transtornos cardiovasculares | |
SE0104334D0 (sv) | Therapeutic agents | |
IS2598B (is) | Þíenópýrimidíndíón og notkun þeirra í mótun sjálfnæmissjúkdóma | |
HK57197A (en) | Naphthalene derivatives procedure for their preparation and pharmaceutical compositions containing them | |
CO5271691A1 (es) | Nuevos compuestos | |
RU2003134544A (ru) | Амиды антраниловой кислоты, способы их получения, их применение в качестве антиаритмических средств, а также содержащие их фармацевтические композиции | |
BR0014596A (pt) | Derivado de pirimidina, uso do mesmo, composição farmacêutica, e, método de tratar doenças ou condições médicas mediadas por citocinas | |
BR0313846A (pt) | Derivados de dioxano-2-alquilcarbamatos, sua preparação e sua aplicação em terapêutica | |
DE60039359D1 (de) | Amide als pyruvatdehydrogenaseinhibitoren | |
RU2007122406A (ru) | Производные тетралина и индана и их применения в качестве антагонистов 5-нт | |
RU2007123251A (ru) | Производные хромана и их применение в качестве лигандов 5-нт рецептора | |
DE69229442D1 (de) | Substituierte dibenzooxazepin-verbindungen, pharmazeutische zusammensetzungen und verfahren zur verwendung | |
SE9903997D0 (sv) | New compounds | |
RU2002110328A (ru) | Препарат замещенных бензимидазолов | |
SE0201658D0 (sv) | Immediate release pharmaceutical formulation | |
ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
CA2425199A1 (en) | Formulation of substituted benzimidazoles | |
KR910004568A (ko) | 치환 n-(퀴놀린-2-일-메톡시)벤질-술포닐우레아 | |
AP9901578A0 (en) | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents. | |
KR910000647A (ko) | 나프틸아미노-및 나프틸옥시- 피리딘아민 및 관련된 화합물, 이의 제조방법 및 이의 피부소염제로서의 용도 | |
SE0104333D0 (sv) | Therapeutic agents | |
DE60031699D1 (de) | Hydroxyacetamidobenzolsulfonamidderivate | |
DE69930621D1 (de) | Medizinische zusammensetzungen zur unmittelbaren freisetzung bei oraler anwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |